Eli Lilly and Co (LLY)
324.71
+0.48 (+0.15%)
USD |
NYSE |
Jul 01, 16:00
324.71
0.00 (0.00%)
Pre-Market: 20:00
Eli Lilly Profit Margin (Quarterly): 24.36% for March 31, 2022
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 24.36% |
| December 31, 2021 | 21.58% |
| September 30, 2021 | 16.39% |
| June 30, 2021 | 20.63% |
| March 31, 2021 | 19.91% |
| December 31, 2020 | 28.45% |
| September 30, 2020 | 21.05% |
| June 30, 2020 | 25.68% |
| March 31, 2020 | 24.86% |
| December 31, 2019 | 24.46% |
| September 30, 2019 | 22.90% |
| June 30, 2019 | 23.55% |
| March 31, 2019 | 83.30% |
| December 31, 2018 | 19.96% |
| September 30, 2018 | 21.66% |
| June 30, 2018 | -4.65% |
| March 31, 2018 | 24.53% |
| December 31, 2017 | -50.78% |
| September 30, 2017 | 9.82% |
| June 30, 2017 | 17.31% |
| March 31, 2017 | -2.12% |
| December 31, 2016 | 13.40% |
| September 30, 2016 | 14.99% |
| June 30, 2016 | 13.83% |
| March 31, 2016 | 9.05% |
| Date | Value |
|---|---|
| December 31, 2015 | 8.90% |
| September 30, 2015 | 16.12% |
| June 30, 2015 | 12.07% |
| March 31, 2015 | 11.40% |
| December 31, 2014 | 8.37% |
| September 30, 2014 | 10.27% |
| June 30, 2014 | 14.86% |
| March 31, 2014 | 15.54% |
| December 31, 2013 | 12.52% |
| September 30, 2013 | 20.84% |
| June 30, 2013 | 20.34% |
| March 31, 2013 | 27.63% |
| December 31, 2012 | 13.89% |
| September 30, 2012 | 24.37% |
| June 30, 2012 | 16.49% |
| March 31, 2012 | 18.05% |
| December 31, 2011 | 14.19% |
| September 30, 2011 | 20.11% |
| June 30, 2011 | 19.15% |
| March 31, 2011 | 18.08% |
| December 31, 2010 | 18.90% |
| September 30, 2010 | 23.04% |
| June 30, 2010 | 23.46% |
| March 31, 2010 | 22.75% |
| December 31, 2009 | 15.43% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-50.78%
Minimum
Dec 2017
83.30%
Maximum
Mar 2019
19.88%
Average
21.66%
Median
Sep 2018
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 36.33% |
| Johnson & Johnson | 21.98% |
| Merck & Co Inc | 27.11% |
| Pfizer Inc | 30.65% |
| AbbVie Inc | 33.17% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 77.76% |
| Return on Assets | 12.85% |
| Return on Invested Capital | 24.81% |
| Gross Profit Margin (Quarterly) | 73.47% |
| Operating Margin (Quarterly) | 32.91% |
| Return on Net Operating Assets | 17.51% |